Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Medical Contrast Agent market report explains the definition, types, applications, major countries, and major players of the Medical Contrast Agent market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Subhra Pharma Private
Bracco Imaging
Spago Nanomedical
Lantheus Medical Imaging
GE Healthcare
CMC Contrast
Bayer
Daiichi Sankyo
Guerbet Group
Nanopet Pharma
By Type:
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
By End-User:
Cardiovascular Disorders
Neurological Disorders
Gastrointestinal Disorders
Cancer
Nephrological Disorders
Musculoskeletal Disorders
Other Applications
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Medical Contrast Agent Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Medical Contrast Agent Outlook to 2028- Original Forecasts
-
2.2 Medical Contrast Agent Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Medical Contrast Agent Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Medical Contrast Agent Market- Recent Developments
-
6.1 Medical Contrast Agent Market News and Developments
-
6.2 Medical Contrast Agent Market Deals Landscape
7 Medical Contrast Agent Raw Materials and Cost Structure Analysis
-
7.1 Medical Contrast Agent Key Raw Materials
-
7.2 Medical Contrast Agent Price Trend of Key Raw Materials
-
7.3 Medical Contrast Agent Key Suppliers of Raw Materials
-
7.4 Medical Contrast Agent Market Concentration Rate of Raw Materials
-
7.5 Medical Contrast Agent Cost Structure Analysis
-
7.5.1 Medical Contrast Agent Raw Materials Analysis
-
7.5.2 Medical Contrast Agent Labor Cost Analysis
-
7.5.3 Medical Contrast Agent Manufacturing Expenses Analysis
8 Global Medical Contrast Agent Import and Export Analysis (Top 10 Countries)
-
8.1 Global Medical Contrast Agent Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Medical Contrast Agent Export by Region (Top 10 Countries) (2017-2028)
9 Global Medical Contrast Agent Market Outlook by Types and Applications to 2022
-
9.1 Global Medical Contrast Agent Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Barium-based Contrast Media Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Iodinated Contrast Media Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Gadolinium-based Contrast Media Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Microbubble Contrast Media Consumption and Growth Rate (2017-2022)
-
9.2 Global Medical Contrast Agent Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cardiovascular Disorders Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Neurological Disorders Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Gastrointestinal Disorders Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Nephrological Disorders Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Musculoskeletal Disorders Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Other Applications Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Medical Contrast Agent Market Analysis and Outlook till 2022
-
10.1 Global Medical Contrast Agent Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Medical Contrast Agent Consumption (2017-2022)
-
10.2.2 Canada Medical Contrast Agent Consumption (2017-2022)
-
10.2.3 Mexico Medical Contrast Agent Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Medical Contrast Agent Consumption (2017-2022)
-
10.3.2 UK Medical Contrast Agent Consumption (2017-2022)
-
10.3.3 Spain Medical Contrast Agent Consumption (2017-2022)
-
10.3.4 Belgium Medical Contrast Agent Consumption (2017-2022)
-
10.3.5 France Medical Contrast Agent Consumption (2017-2022)
-
10.3.6 Italy Medical Contrast Agent Consumption (2017-2022)
-
10.3.7 Denmark Medical Contrast Agent Consumption (2017-2022)
-
10.3.8 Finland Medical Contrast Agent Consumption (2017-2022)
-
10.3.9 Norway Medical Contrast Agent Consumption (2017-2022)
-
10.3.10 Sweden Medical Contrast Agent Consumption (2017-2022)
-
10.3.11 Poland Medical Contrast Agent Consumption (2017-2022)
-
10.3.12 Russia Medical Contrast Agent Consumption (2017-2022)
-
10.3.13 Turkey Medical Contrast Agent Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Medical Contrast Agent Consumption (2017-2022)
-
10.4.2 Japan Medical Contrast Agent Consumption (2017-2022)
-
10.4.3 India Medical Contrast Agent Consumption (2017-2022)
-
10.4.4 South Korea Medical Contrast Agent Consumption (2017-2022)
-
10.4.5 Pakistan Medical Contrast Agent Consumption (2017-2022)
-
10.4.6 Bangladesh Medical Contrast Agent Consumption (2017-2022)
-
10.4.7 Indonesia Medical Contrast Agent Consumption (2017-2022)
-
10.4.8 Thailand Medical Contrast Agent Consumption (2017-2022)
-
10.4.9 Singapore Medical Contrast Agent Consumption (2017-2022)
-
10.4.10 Malaysia Medical Contrast Agent Consumption (2017-2022)
-
10.4.11 Philippines Medical Contrast Agent Consumption (2017-2022)
-
10.4.12 Vietnam Medical Contrast Agent Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Medical Contrast Agent Consumption (2017-2022)
-
10.5.2 Colombia Medical Contrast Agent Consumption (2017-2022)
-
10.5.3 Chile Medical Contrast Agent Consumption (2017-2022)
-
10.5.4 Argentina Medical Contrast Agent Consumption (2017-2022)
-
10.5.5 Venezuela Medical Contrast Agent Consumption (2017-2022)
-
10.5.6 Peru Medical Contrast Agent Consumption (2017-2022)
-
10.5.7 Puerto Rico Medical Contrast Agent Consumption (2017-2022)
-
10.5.8 Ecuador Medical Contrast Agent Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Medical Contrast Agent Consumption (2017-2022)
-
10.6.2 Kuwait Medical Contrast Agent Consumption (2017-2022)
-
10.6.3 Oman Medical Contrast Agent Consumption (2017-2022)
-
10.6.4 Qatar Medical Contrast Agent Consumption (2017-2022)
-
10.6.5 Saudi Arabia Medical Contrast Agent Consumption (2017-2022)
-
10.6.6 United Arab Emirates Medical Contrast Agent Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Medical Contrast Agent Consumption (2017-2022)
-
10.7.2 South Africa Medical Contrast Agent Consumption (2017-2022)
-
10.7.3 Egypt Medical Contrast Agent Consumption (2017-2022)
-
10.7.4 Algeria Medical Contrast Agent Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Medical Contrast Agent Consumption (2017-2022)
-
10.8.2 New Zealand Medical Contrast Agent Consumption (2017-2022)
11 Global Medical Contrast Agent Competitive Analysis
-
11.1 Subhra Pharma Private
-
11.1.1 Subhra Pharma Private Company Details
-
11.1.2 Subhra Pharma Private Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Subhra Pharma Private Medical Contrast Agent Main Business and Markets Served
-
11.1.4 Subhra Pharma Private Medical Contrast Agent Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Bracco Imaging
-
11.2.1 Bracco Imaging Company Details
-
11.2.2 Bracco Imaging Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Bracco Imaging Medical Contrast Agent Main Business and Markets Served
-
11.2.4 Bracco Imaging Medical Contrast Agent Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Spago Nanomedical
-
11.3.1 Spago Nanomedical Company Details
-
11.3.2 Spago Nanomedical Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Spago Nanomedical Medical Contrast Agent Main Business and Markets Served
-
11.3.4 Spago Nanomedical Medical Contrast Agent Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Lantheus Medical Imaging
-
11.4.1 Lantheus Medical Imaging Company Details
-
11.4.2 Lantheus Medical Imaging Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Lantheus Medical Imaging Medical Contrast Agent Main Business and Markets Served
-
11.4.4 Lantheus Medical Imaging Medical Contrast Agent Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 GE Healthcare
-
11.5.1 GE Healthcare Company Details
-
11.5.2 GE Healthcare Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 GE Healthcare Medical Contrast Agent Main Business and Markets Served
-
11.5.4 GE Healthcare Medical Contrast Agent Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 CMC Contrast
-
11.6.1 CMC Contrast Company Details
-
11.6.2 CMC Contrast Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 CMC Contrast Medical Contrast Agent Main Business and Markets Served
-
11.6.4 CMC Contrast Medical Contrast Agent Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Bayer
-
11.7.1 Bayer Company Details
-
11.7.2 Bayer Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Bayer Medical Contrast Agent Main Business and Markets Served
-
11.7.4 Bayer Medical Contrast Agent Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Daiichi Sankyo
-
11.8.1 Daiichi Sankyo Company Details
-
11.8.2 Daiichi Sankyo Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Daiichi Sankyo Medical Contrast Agent Main Business and Markets Served
-
11.8.4 Daiichi Sankyo Medical Contrast Agent Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Guerbet Group
-
11.9.1 Guerbet Group Company Details
-
11.9.2 Guerbet Group Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Guerbet Group Medical Contrast Agent Main Business and Markets Served
-
11.9.4 Guerbet Group Medical Contrast Agent Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Nanopet Pharma
-
11.10.1 Nanopet Pharma Company Details
-
11.10.2 Nanopet Pharma Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Nanopet Pharma Medical Contrast Agent Main Business and Markets Served
-
11.10.4 Nanopet Pharma Medical Contrast Agent Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Medical Contrast Agent Market Outlook by Types and Applications to 2028
-
12.1 Global Medical Contrast Agent Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Barium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Iodinated Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Gadolinium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Microbubble Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Medical Contrast Agent Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Cardiovascular Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Gastrointestinal Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Nephrological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Musculoskeletal Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.7 Global Other Applications Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Medical Contrast Agent Market Analysis and Outlook to 2028
-
13.1 Global Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.2.2 Canada Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.2.3 Mexico Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.3.2 UK Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.3.3 Spain Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.3.4 Belgium Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.3.5 France Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.3.6 Italy Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.3.7 Denmark Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.3.8 Finland Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.3.9 Norway Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.3.10 Sweden Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.3.11 Poland Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.3.12 Russia Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.3.13 Turkey Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.4.2 Japan Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.4.3 India Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.4.4 South Korea Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.4.8 Thailand Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.4.9 Singapore Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.4.11 Philippines Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.5.2 Colombia Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.5.3 Chile Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.5.4 Argentina Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.5.6 Peru Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.6.3 Oman Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.6.4 Qatar Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.7.2 South Africa Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.7.3 Egypt Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.7.4 Algeria Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Medical Contrast Agent Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Medical Contrast Agent Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Medical Contrast Agent
-
Figure of Medical Contrast Agent Picture
-
Table Global Medical Contrast Agent Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Medical Contrast Agent Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Barium-based Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Global Iodinated Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Global Gadolinium-based Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Global Microbubble Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Neurological Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Nephrological Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Musculoskeletal Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Other Applications Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Contrast Agent Consumption by Country (2017-2022)
-
Table North America Medical Contrast Agent Consumption by Country (2017-2022)
-
Figure United States Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Canada Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Mexico Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Table Europe Medical Contrast Agent Consumption by Country (2017-2022)
-
Figure Germany Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure UK Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Spain Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Belgium Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure France Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Italy Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Denmark Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Finland Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Norway Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Sweden Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Poland Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Russia Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Turkey Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Table APAC Medical Contrast Agent Consumption by Country (2017-2022)
-
Figure China Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Japan Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure India Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure South Korea Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Thailand Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Singapore Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Philippines Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Table South America Medical Contrast Agent Consumption by Country (2017-2022)
-
Figure Brazil Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Colombia Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Chile Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Argentina Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Peru Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Table GCC Medical Contrast Agent Consumption by Country (2017-2022)
-
Figure Bahrain Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Oman Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Qatar Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Table Africa Medical Contrast Agent Consumption by Country (2017-2022)
-
Figure Nigeria Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure South Africa Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Egypt Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure Algeria Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Table Oceania Medical Contrast Agent Consumption by Country (2017-2022)
-
Figure Australia Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Medical Contrast Agent Consumption and Growth Rate (2017-2022)
-
Table Subhra Pharma Private Company Details
-
Table Subhra Pharma Private Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Subhra Pharma Private Medical Contrast Agent Main Business and Markets Served
-
Table Subhra Pharma Private Medical Contrast Agent Product Portfolio
-
Table Bracco Imaging Company Details
-
Table Bracco Imaging Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bracco Imaging Medical Contrast Agent Main Business and Markets Served
-
Table Bracco Imaging Medical Contrast Agent Product Portfolio
-
Table Spago Nanomedical Company Details
-
Table Spago Nanomedical Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spago Nanomedical Medical Contrast Agent Main Business and Markets Served
-
Table Spago Nanomedical Medical Contrast Agent Product Portfolio
-
Table Lantheus Medical Imaging Company Details
-
Table Lantheus Medical Imaging Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lantheus Medical Imaging Medical Contrast Agent Main Business and Markets Served
-
Table Lantheus Medical Imaging Medical Contrast Agent Product Portfolio
-
Table GE Healthcare Company Details
-
Table GE Healthcare Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Medical Contrast Agent Main Business and Markets Served
-
Table GE Healthcare Medical Contrast Agent Product Portfolio
-
Table CMC Contrast Company Details
-
Table CMC Contrast Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table CMC Contrast Medical Contrast Agent Main Business and Markets Served
-
Table CMC Contrast Medical Contrast Agent Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Medical Contrast Agent Main Business and Markets Served
-
Table Bayer Medical Contrast Agent Product Portfolio
-
Table Daiichi Sankyo Company Details
-
Table Daiichi Sankyo Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Medical Contrast Agent Main Business and Markets Served
-
Table Daiichi Sankyo Medical Contrast Agent Product Portfolio
-
Table Guerbet Group Company Details
-
Table Guerbet Group Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Guerbet Group Medical Contrast Agent Main Business and Markets Served
-
Table Guerbet Group Medical Contrast Agent Product Portfolio
-
Table Nanopet Pharma Company Details
-
Table Nanopet Pharma Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nanopet Pharma Medical Contrast Agent Main Business and Markets Served
-
Table Nanopet Pharma Medical Contrast Agent Product Portfolio
-
Figure Global Barium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Iodinated Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gadolinium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Microbubble Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nephrological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Musculoskeletal Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Applications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Contrast Agent Consumption Forecast by Country (2022-2028)
-
Table North America Medical Contrast Agent Consumption Forecast by Country (2022-2028)
-
Figure United States Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Medical Contrast Agent Consumption Forecast by Country (2022-2028)
-
Figure Germany Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Medical Contrast Agent Consumption Forecast by Country (2022-2028)
-
Figure China Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Medical Contrast Agent Consumption Forecast by Country (2022-2028)
-
Figure Brazil Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Medical Contrast Agent Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Medical Contrast Agent Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Medical Contrast Agent Consumption Forecast by Country (2022-2028)
-
Figure Australia Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Medical Contrast Agent Consumption Forecast and Growth Rate (2022-2028)
-
